Profile | GDS5420 / 210104_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 676.96 | 72 |
GSM1296119 | B_lesional_pre-dose | 1044.58 | 80 |
GSM1296076 | C_lesional_pre-dose | 1077.34 | 80 |
GSM1296092 | D_lesional_pre-dose | 955.01 | 78 |
GSM1296103 | E_lesional_pre-dose | 686.83 | 73 |
GSM1296078 | F_lesional_pre-dose | 1105.03 | 80 |
GSM1296107 | G_lesional_pre-dose | 889.86 | 77 |
GSM1296109 | H_lesional_pre-dose | 759.2 | 75 |
GSM1296080 | I_lesional_pre-dose | 432.09 | 65 |
GSM1296090 | J_lesional_pre-dose | 1053.19 | 80 |
GSM1296074 | K_lesional_pre-dose | 1003.93 | 79 |
GSM1296111 | L_lesional_pre-dose | 999.07 | 79 |
GSM1296099 | M_lesional_pre-dose | 892.74 | 77 |
GSM1296086 | O_lesional_pre-dose | 919.27 | 78 |
GSM1296117 | P_lesional_pre-dose | 924.16 | 78 |
GSM1296113 | Q_lesional_pre-dose | 695.77 | 73 |
GSM1296096 | R_lesional_pre-dose | 1138.71 | 81 |
GSM1296105 | S_lesional_pre-dose | 651.95 | 72 |
GSM1296098 | T_lesional_pre-dose | 630.63 | 71 |
GSM1296101 | U_lesional_pre-dose | 759.17 | 75 |
GSM1296121 | V_lesional_pre-dose | 911.28 | 78 |
GSM1296088 | W_lesional_pre-dose | 891.34 | 77 |
GSM1296082 | X_lesional_pre-dose | 1444.02 | 84 |
GSM1296115 | Y_lesional_pre-dose | 1079.6 | 80 |
GSM1296084 | Z_lesional_pre-dose | 712.71 | 74 |
GSM1296072 | B_lesional_day8 | 781.66 | 75 |
GSM1296069 | L_lesional_day8 | 837.87 | 77 |
GSM1296071 | P_lesional_day8 | 621.35 | 71 |
GSM1296070 | Y_lesional_day8 | 782.75 | 75 |
GSM1296073 | V_lesional_day8 | 1041.47 | 80 |
GSM1296034 | A_lesional_day15 | 364.29 | 61 |
GSM1296041 | G_lesional_day15 | 1031.88 | 80 |
GSM1296035 | R_lesional_day15 | 959.54 | 78 |
GSM1296038 | U_lesional_day15 | 822.43 | 76 |
GSM1296047 | B_lesional_day15 | 577.83 | 70 |
GSM1296039 | E_lesional_day15 | 922.67 | 78 |
GSM1296042 | H_lesional_day15 | 874.9 | 77 |
GSM1296043 | L_lesional_day15 | 776.15 | 75 |
GSM1296037 | M_lesional_day15 | 461.95 | 66 |
GSM1296046 | P_lesional_day15 | 669.02 | 72 |
GSM1296044 | Q_lesional_day15 | 646.77 | 72 |
GSM1296045 | Y_lesional_day15 | 610.37 | 71 |
GSM1296025 | C_lesional_day15 | 358.2 | 62 |
GSM1296033 | D_lesional_day15 | 525.33 | 68 |
GSM1296027 | I_lesional_day15 | 431.77 | 66 |
GSM1296032 | J_lesional_day15 | 407.42 | 64 |
GSM1296024 | K_lesional_day15 | 345.28 | 62 |
GSM1296031 | W_lesional_day15 | 606.64 | 71 |
GSM1296028 | X_lesional_day15 | 494.92 | 67 |
GSM1296029 | Z_lesional_day15 | 454.17 | 66 |
GSM1296026 | F_lesional_day15 | 618.83 | 71 |
GSM1296030 | O_lesional_day15 | 483.68 | 67 |
GSM1296040 | S_lesional_day15 | 764.43 | 75 |
GSM1296036 | T_lesional_day15 | 447 | 65 |
GSM1296048 | V_lesional_day15 | 909.53 | 78 |
GSM1296059 | A_lesional_day43 | 690.37 | 73 |
GSM1296066 | G_lesional_day43 | 858.45 | 77 |
GSM1296060 | R_lesional_day43 | 895.6 | 77 |
GSM1296063 | U_lesional_day43 | 940.78 | 78 |
GSM1296064 | E_lesional_day43 | 1048.03 | 80 |
GSM1296067 | H_lesional_day43 | 576.33 | 70 |
GSM1296062 | M_lesional_day43 | 582.49 | 70 |
GSM1296068 | Q_lesional_day43 | 541.42 | 68 |
GSM1296050 | C_lesional_day43 | 543.38 | 69 |
GSM1296057 | D_lesional_day43 | 615.47 | 71 |
GSM1296052 | I_lesional_day43 | 389.19 | 64 |
GSM1296054 | J_lesional_day43 | 468.56 | 66 |
GSM1296049 | K_lesional_day43 | 432.44 | 65 |
GSM1296055 | W_lesional_day43 | 672.42 | 72 |
GSM1296053 | X_lesional_day43 | 610.69 | 71 |
GSM1296058 | Z_lesional_day43 | 562.54 | 69 |
GSM1296051 | F_lesional_day43 | 735.6 | 74 |
GSM1296056 | O_lesional_day43 | 1045.4 | 79 |
GSM1296065 | S_lesional_day43 | 862.64 | 77 |
GSM1296061 | T_lesional_day43 | 459.21 | 65 |
GSM1296095 | A_non-lesional_pre-dose | 867.72 | 77 |
GSM1296120 | B_non-lesional_pre-dose | 667.86 | 73 |
GSM1296077 | C_non-lesional_pre-dose | 395.13 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 307.08 | 59 |
GSM1296104 | E_non-lesional_pre-dose | 830.67 | 76 |
GSM1296079 | F_non-lesional_pre-dose | 526.55 | 69 |
GSM1296108 | G_non-lesional_pre-dose | 661.67 | 72 |
GSM1296110 | H_non-lesional_pre-dose | 674.76 | 72 |
GSM1296081 | I_non-lesional_pre-dose | 492.08 | 68 |
GSM1296091 | J_non-lesional_pre-dose | 628.43 | 71 |
GSM1296075 | K_non-lesional_pre-dose | 575.03 | 71 |
GSM1296112 | L_non-lesional_pre-dose | 619.95 | 71 |
GSM1296100 | M_non-lesional_pre-dose | 607.01 | 71 |
GSM1296087 | O_non-lesional_pre-dose | 409.24 | 65 |
GSM1296118 | P_non-lesional_pre-dose | 553.31 | 69 |
GSM1296114 | Q_non-lesional_pre-dose | 588.66 | 70 |
GSM1296097 | R_non-lesional_pre-dose | 795.98 | 75 |
GSM1296106 | S_non-lesional_pre-dose | 757.11 | 75 |
GSM1296102 | U_non-lesional_pre-dose | 560.93 | 69 |
GSM1296122 | V_non-lesional_pre-dose | 567.4 | 70 |
GSM1296089 | W_non-lesional_pre-dose | 627.95 | 71 |
GSM1296083 | X_non-lesional_pre-dose | 566.21 | 69 |
GSM1296116 | Y_non-lesional_pre-dose | 674.89 | 73 |
GSM1296085 | Z_non-lesional_pre-dose | 308.01 | 59 |